Atorvastatin in Combination with Pegylated Interferon and Ribavirin Provided High Rate of Sustained Virological Response in Patients with Genotype 3 Hepatitis C Virus

BACKGROUND: Chronic hepatitis C virus infection represents a more frequent cause of liver cirrhosis and hepatocellular carcinoma. Statins, inhibit HCV replication in vitro, enhance the antiviral effect of the already known antiviral drugs and reduce their resistance. AIM: To determine the impact of...

Descripción completa

Detalles Bibliográficos
Autores principales: Todorovska, Beti, Caloska-Ivanova, Viktorija, Dimitrova-Genadieva, Magdalena, Trajkovska, Meri, Popova-Jovanovska, Rozalinda, Grivceva-Stardelova, Kalina, Licoska-Josifovic, Fana, Andreevski, Vladimir, Curakova-Ristovska, Elena, Joksimovic, Nenad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Republic of Macedonia 2019
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560281/
https://www.ncbi.nlm.nih.gov/pubmed/31210815
http://dx.doi.org/10.3889/oamjms.2019.459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560281/
https://www.ncbi.nlm.nih.gov/pubmed/31210815
http://dx.doi.org/10.3889/oamjms.2019.459

Ejemplares similares